In the last completed session, Mankind Pharma Ltd. closed +3.02% with futures open interest moving +1.4%. That combination — price rising while OI builds — is classified as a Long Buildup, meaning derivative traders are adding fresh bullish positions into strength rather than merely covering existing shorts. The stock's option PCR sits at 0.51, indicating heavy call-side writing — option dealers see resistance overhead.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Mankind Pharma Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Mankind Pharma Ltd. points to a supportive setup at the next open.
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
| 2240 |
IV 29%
Δ -0.21
θ -0.9
ν 2
|
|
|
IV 55%
Δ 0.66
θ -2.6
ν 2
|
2260 |
IV 29%
Δ -0.24
θ -1.0
ν 2
|
| 2280 |
IV 29%
Δ -0.28
θ -1.0
ν 2
|
|
|
IV 34%
Δ 0.66
θ -1.7
ν 2
|
2300 S |
IV 29%
Δ -0.32
θ -1.1
ν 2
|
|
IV 33%
Δ 0.63
θ -1.7
ν 2
|
2320 |
IV 28%
Δ -0.35
θ -1.1
ν 2
|
|
IV 33%
Δ 0.59
θ -1.8
ν 2
|
2340 |
IV 28%
Δ -0.40
θ -1.1
ν 2
|
|
IV 33%
Δ 0.56
θ -1.8
ν 3
|
2360 |
IV 28%
Δ -0.44
θ -1.1
ν 3
|
|
IV 33%
Δ 0.52
θ -1.8
ν 3
|
2380 MP |
IV 28%
Δ -0.48
θ -1.1
ν 3
|
|
IV 33%
Δ 0.48
θ -1.7
ν 3
|
2400 |
IV 28%
Δ -0.53
θ -1.1
ν 3
|
|
IV 32%
Δ 0.44
θ -1.7
ν 3
|
2420 |
IV 44%
Δ -0.53
θ -1.8
ν 3
|
|
IV 33%
Δ 0.41
θ -1.7
ν 2
|
2440 |
IV 48%
Δ -0.55
θ -2.0
ν 3
|
|
IV 32%
Δ 0.37
θ -1.6
ν 2
|
2460 |
IV 28%
Δ -0.65
θ -0.9
ν 2
|
|
IV 33%
Δ 0.34
θ -1.6
ν 2
|
2480 |
IV 44%
Δ -0.61
θ -1.7
ν 2
|